cilostazol has been researched along with Carotid Artery Narrowing in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the effects of cilostazol 200 mg, in addition to aspirin 100 mg and clopidogrel 75 mg, on carotid intima-media thickness (IMT) progression during a 2-year follow-up period in patients with acute coronary syndrome (ACS) requiring stent implantation." | 9.15 | Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. ( Ahn, CM; Hong, SJ; Kim, JS; Lim, DS; Park, JH, 2011) |
| " Diabetes mellitus and current smoker status were independent factors related to reactivity to clopidogrel." | 7.83 | Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures. ( Hironaka, Y; Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Takayama, K; Wada, T; Yokoyama, S, 2016) |
| " We investigated the effects of cilostazol 200 mg, in addition to aspirin 100 mg and clopidogrel 75 mg, on carotid intima-media thickness (IMT) progression during a 2-year follow-up period in patients with acute coronary syndrome (ACS) requiring stent implantation." | 5.15 | Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. ( Ahn, CM; Hong, SJ; Kim, JS; Lim, DS; Park, JH, 2011) |
| "Cilostazol seems to decrease total ISR rates in patients undergoing CAS without affecting MI/stroke/death events, both in the early and late settings." | 4.93 | Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes After Carotid Stenting. ( Aggeli, K; Filis, K; Galyfos, G; Geropapas, G; Sianou, A; Sigala, F, 2016) |
| " Diabetes mellitus and current smoker status were independent factors related to reactivity to clopidogrel." | 3.83 | Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures. ( Hironaka, Y; Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Takayama, K; Wada, T; Yokoyama, S, 2016) |
| " We performed cognitive behavioral tests, including the water maze task, odor discrimination task, and novel object test; histological investigation of neuroinflammation, oligodendrocytes, myelin basic protein, and nodal or paranodal proteins at the nodes of Ranvier; and serial diffusion tensor imaging." | 3.83 | Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion. ( Back, DB; Choi, BR; Choi, DH; Han, JS; Han, SH; Kang, CH; Kim, BR; Kim, DH; Kim, HY; Kwon, KJ; Lee, J; Moon, WJ; Shin, CY, 2016) |
| "Bilateral common carotid artery stenosis (BCAS) mice were treated with oral administration of cilostazol or placebo starting from a week after the surgery." | 1.48 | Cilostazol alleviates white matter degeneration caused by chronic cerebral hypoperfusion in mice: Implication of its mechanism from gene expression analysis. ( Bannai, T; Iwata, A; Ohtomo, G; Ohtomo, R; Shindo, A; Tomimoto, H; Tsuji, S, 2018) |
| "A total of 949 patients with cervical carotid artery stenosis were enrolled at 43 institutions in Japan; 934 who had undergone CAS with antiplatelet drugs and followed for 1 year were analyzed." | 1.40 | Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting. ( Ezura, M; Hyodo, A; Matsubara, Y; Matsumaru, Y; Matsumoto, Y; Miyachi, S; Nakamura, M; Okada, Y; Sakai, C; Sakai, N; Terada, T; Yamagami, H; Yokoi, H, 2014) |
| "Cilostazol is a potent type III phosphodiesterase inhibitor, approved as an anti-platelet aggregation agent." | 1.35 | Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model. ( Hattori, N; Miyamoto, N; Mochizuki, H; Tanaka, R; Urabe, T; Zhang, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 17 (80.95) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohtomo, R | 1 |
| Bannai, T | 1 |
| Ohtomo, G | 1 |
| Shindo, A | 1 |
| Tomimoto, H | 1 |
| Tsuji, S | 1 |
| Iwata, A | 1 |
| Park, SY | 1 |
| Kim, HY | 2 |
| Lee, YS | 1 |
| Heo, HJ | 1 |
| Shin, HK | 1 |
| Lee, WS | 1 |
| Hong, KW | 1 |
| Kim, CD | 1 |
| Tsutsumi, M | 1 |
| Aikawa, H | 1 |
| Nii, K | 1 |
| Etou, H | 1 |
| Sakamoto, K | 1 |
| Kureshima, M | 1 |
| Inoue, R | 1 |
| Yoshida, H | 1 |
| Matsumoto, Y | 3 |
| Narita, S | 1 |
| Kazekawa, K | 1 |
| Tanaka, H | 1 |
| Zaima, N | 1 |
| Ito, H | 1 |
| Hattori, K | 1 |
| Yamamoto, N | 1 |
| Konno, H | 1 |
| Setou, M | 1 |
| Unno, N | 1 |
| Nakagawa, I | 3 |
| Wada, T | 3 |
| Park, HS | 3 |
| Nishimura, F | 1 |
| Yamada, S | 2 |
| Nakagawa, H | 1 |
| Kichikawa, K | 3 |
| Nakase, H | 3 |
| Fukuoka, T | 1 |
| Hayashi, T | 1 |
| Hirayama, M | 1 |
| Maruyama, H | 1 |
| Tanahashi, N | 1 |
| Sakai, N | 2 |
| Yamagami, H | 2 |
| Matsubara, Y | 1 |
| Ezura, M | 1 |
| Hyodo, A | 2 |
| Matsumaru, Y | 2 |
| Miyachi, S | 2 |
| Okada, Y | 1 |
| Terada, T | 1 |
| Yokoi, H | 1 |
| Nakamura, M | 1 |
| Sakai, C | 2 |
| Miyazaki, Y | 1 |
| Mori, T | 1 |
| Iwata, T | 1 |
| Aoyagi, Y | 1 |
| Tanno, Y | 1 |
| Kasakura, S | 1 |
| Yoshioka, K | 1 |
| Yokoyama, S | 2 |
| Hironaka, Y | 1 |
| Motoyama, Y | 2 |
| Takayama, K | 1 |
| Galyfos, G | 1 |
| Geropapas, G | 1 |
| Sigala, F | 1 |
| Aggeli, K | 1 |
| Sianou, A | 1 |
| Filis, K | 1 |
| Choi, BR | 1 |
| Kim, DH | 1 |
| Back, DB | 1 |
| Kang, CH | 1 |
| Moon, WJ | 1 |
| Han, JS | 1 |
| Choi, DH | 1 |
| Kwon, KJ | 1 |
| Shin, CY | 1 |
| Kim, BR | 1 |
| Lee, J | 1 |
| Han, SH | 1 |
| Zhang, N | 2 |
| Miyamoto, N | 2 |
| Tanaka, R | 2 |
| Mochizuki, H | 2 |
| Hattori, N | 2 |
| Urabe, T | 2 |
| Shimura, H | 1 |
| Onodera, M | 1 |
| Yoshimoto, T | 1 |
| Fujimoto, S | 1 |
| Muraki, M | 1 |
| Kobayashi, R | 1 |
| Yoshidumi, T | 1 |
| Yamauchi, T | 1 |
| Tokuda, K | 1 |
| Kaneko, S | 1 |
| Kai, Y | 1 |
| Sugiu, K | 1 |
| Fujinaka, T | 1 |
| Yoshimura, S | 1 |
| Hyogo, T | 1 |
| Kuwayama, N | 1 |
| Ahn, CM | 1 |
| Hong, SJ | 1 |
| Park, JH | 1 |
| Kim, JS | 1 |
| Lim, DS | 1 |
| Yamaguchi, M | 1 |
| Sasaki, M | 1 |
| Ohba, H | 1 |
| Mori, K | 1 |
| Narumi, S | 1 |
| Katsura, N | 1 |
| Ohura, K | 1 |
| Kudo, K | 1 |
| Terayama, Y | 1 |
| Kato, T | 1 |
| Sakai, H | 1 |
| Takagi, T | 1 |
| Nishimura, Y | 1 |
| Nighoghossian, N | 1 |
| Derex, L | 1 |
| Douek, P | 1 |
| Akaji, K | 1 |
| Tanizaki, Y | 1 |
| Hiraga, K | 1 |
| Akiyama, T | 1 |
| Dembo, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Deep Learning Model Based on Routine Ultrasound Scanning Video to Help Doctors Improve the Diagnosis of Carotid Plaque[NCT05230576] | 2,000 participants (Actual) | Observational | 2020-05-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cilostazol and Carotid Artery Narrowing
| Article | Year |
|---|---|
Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes After Carotid Stenting.
Topics: Angioplasty; Cardiovascular Agents; Carotid Stenosis; Chi-Square Distribution; Cilostazol; Humans; M | 2016 |
The vulnerable carotid artery plaque: current imaging methods and new perspectives.
Topics: Anticoagulants; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Cilostazol; Diag | 2005 |
5 trials available for cilostazol and Carotid Artery Narrowing
| Article | Year |
|---|---|
Cilostazol reduces periprocedural hemodynamic depression in carotid artery stenting.
Topics: Aged; Angioplasty; Bradycardia; Carotid Stenosis; Cilostazol; Clopidogrel; Female; Humans; Hypotensi | 2013 |
Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combinati | 2017 |
Cilostazol may suppress restenosis and new contralateral carotid artery stenosis after carotid endarterectomy.
Topics: Aged; Carotid Stenosis; Cilostazol; Endarterectomy, Carotid; Female; Humans; Male; Platelet Aggregat | 2010 |
Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Corona | 2011 |
Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting.
Topics: Aged; Aged, 80 and over; Blood Vessel Prosthesis; Carotid Stenosis; Cilostazol; Female; Fibrinolytic | 2012 |
14 other studies available for cilostazol and Carotid Artery Narrowing
| Article | Year |
|---|---|
Cilostazol alleviates white matter degeneration caused by chronic cerebral hypoperfusion in mice: Implication of its mechanism from gene expression analysis.
Topics: Animals; Brain; Carotid Stenosis; Cell Differentiation; Cilostazol; Corpus Callosum; Gene Expression | 2018 |
Augmented improvement of cognition and memory by aripiprazole add-on for cilostazol treatment in the chronic cerebral hypoperfusion mouse model.
Topics: Animals; Aripiprazole; Brain; Brain Ischemia; Carotid Stenosis; Cilostazol; Cognition; Cognitive Dys | 2019 |
Cilostazol inhibits accumulation of triglycerides in a rat model of carotid artery ligation.
Topics: Animals; Cardiovascular Agents; Carotid Artery, Common; Carotid Stenosis; Cholesterol, HDL; Cilostaz | 2013 |
Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
Topics: Aged; Angioplasty; Aspirin; Brain Ischemia; Carotid Stenosis; Cilostazol; Clopidogrel; Diffusion Mag | 2014 |
Cilostazol inhibits leukocyte-endothelial cell interactions in murine microvessels after transient bilateral common carotid artery occlusion.
Topics: Animals; Carotid Stenosis; Cilostazol; Disease Models, Animal; Dose-Response Relationship, Drug; End | 2014 |
Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Carotid Stenosis; Cilostazol; Clopidogrel; Drug | 2014 |
Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions.
Topics: Aged; Aged, 80 and over; Angiography; Carotid Artery, Common; Carotid Stenosis; Cilostazol; Drug Adm | 2016 |
Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Dia | 2016 |
Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion.
Topics: Animals; Behavior, Animal; Brain Ischemia; Carotid Stenosis; Chronic Disease; Cilostazol; Cognition; | 2016 |
Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model.
Topics: Animals; Bacteria; Carotid Stenosis; Chronic Disease; Cilostazol; Corpus Striatum; Cyclic AMP Respon | 2009 |
Crucial role for Ser133-phosphorylated form of cyclic AMP-responsive element binding protein signaling in the differentiation and survival of neural progenitors under chronic cerebral hypoperfusion.
Topics: Animals; Apoptosis; Brain Ischemia; Carotid Stenosis; Cerebral Ventricles; Cerebrovascular Circulati | 2009 |
Periprocedural cilostazol treatment and restenosis after carotid artery stenting: the Retrospective Study of In-Stent Restenosis after Carotid Artery Stenting (ReSISteR-CAS).
Topics: Aged; Carotid Stenosis; Cilostazol; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Pl | 2012 |
Quantitative assessment of changes in carotid plaques during cilostazol administration using three-dimensional ultrasonography and non-gated magnetic resonance plaque imaging.
Topics: Aged; Carotid Stenosis; Cilostazol; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance I | 2012 |
[A case of carotid stenting via the transbrachial approach in the bovine arch].
Topics: Aged; Aspirin; Brachial Artery; Carotid Artery, Common; Carotid Artery, Internal; Carotid Stenosis; | 2006 |